Introducing biosimilar competition for cell and gene therapy products

2024-7-1

Death and the artificial placenta

2024-7-1

Regulating embryo models in the UK

2024-7-1

Bedside manufacturing as the next step in personalized medicine: medical progress and legal challenges

2024-7-1

Considerations on expanding criminal offender DNA databases with Y-STR profiles

2024-7-1

Industry price guarantees for publicly funded medicines: learning from Project NextGen for pandemics and beyond

2024-7-1

The pressing need for FDA regulation of tattoo ink

2024-7-1

Implementing the human right to science in neuroscience

2024-5-14

How AI challenges the medical device regulation: patient safety, benefits, and intended uses

2024-4-9

Certificates of confidentiality: privileging research data

2024-1-1

COVID-19 pediatric vaccine authorization, FDA authority, and individual misperception of risk

2024-1-1

Ethical, legal, and policy challenges in field-based neuroimaging research using emerging portable MRI technologies: guidance for investigators and for oversight

2024-1-1

CRISPR-phage antibacterials to address the antibiotic resistance crisis: scientific, economic, and regulatory considerations

2024-1-1

Sorry you asked? <i>Mayo, Myriad</i>, and the battles over patent-eligibility

2024-1-1

Erratum to: U.S. public perceptions of the sensitivity of brain data

2024-1-1

U.S. public perceptions of the sensitivity of brain data

2024-1-1

The regulation of health data sharing in Africa: a comparative study

2024-1-1

Anticipation in the biosciences and the human right to science

2024-1-1

Illegal interlocks among life science company boards of directors

2024-1-1

Purpose definition as a crucial step for determining the legal basis under the GDPR: implications for scientific research

2024-1-1

Implementing the human right to science in the context of health-related data processing

2024-1-1

Payer reimbursement practices and incentives for improving interpretation of germline genetic testing

2023-7-1

The right to terminate pregnancy (abortion): reflections from Turkey

2023-7-1

<i>‘The law is very, very outdated and not keeping up with the technology’:</i> novel forms of assisted gestation, legal challenges, and perspectives of reproductive rights advocates in England and Wales

2023-7-1

Doctors’ duty to provide abortion information

2023-7-1

Policy options to facilitate cancer genomic variant data sharing: outcomes of a modified policy Delphi

2023-7-1

Neuroethics guidance documents: principles, analysis, and implementation strategies

2023-7-1

How penalizing substance use in pregnancy affects treatment and research: a qualitative examination of researchers’ perspectives

2023-7-1

Terms and conditions apply: an ethical analysis of mobile health user agreements in research

2023-7-1

Implementing the human right to science in the regulatory governance of artificial intelligence in healthcare

2023-7-1

Patent term extension and test data protection obligations: identifying the gap in policy, research, and practice of implementing free trade agreements

2023-7-1

Open science in play and in tension with patent protections

2023-7-1

Genetic data are not always personal—disaggregating the identifiability and sensitivity of genetic data

2023-7-1

Defusing the legal and ethical minefield of epigenetic applications in the military, defense, and security context

2023-7-1

The AI cycle of health inequity and digital ageism: mitigating biases through the EU regulatory framework on medical devices

2023-7-1

Leading with the trailing edge: facilitating patient choice for insulin products

2023-7-1

Cryopreservation and current legal problems: seeking and selling immortality

2023-7-1

FDA preemption of conflicting state drug regulation and the looming battle over abortion medications

2023-1-1

The legal personhood of human brain organoids

2023-1-1

Ectogestation and the Good Samaritan Argument

2023-1-1

The various faces of vulnerability: offering neurointerventions to criminal offenders

2023-1-1

Legal personhood and frozen embryos: implications for fertility patients and providers in post-<i>Roe</i> America

2023-1-1

Is benefit sharing with research participants lawful in South Africa? An unexplored question in the governance of genomics research

2023-1-1

Should Canada adopt managed access agreements in Canada for expensive drugs?

2023-1-1

Governing nonconventional genetic experimentation

2023-1-1

Confidentiality, public interest, and the human right to science: when can confidential information be used for the benefit of the wider community?

2023-1-1

Lessons from Canada’s notice of compliance with conditions policy for the life-cycle regulation of drugs

2023-1-1

Why reason-based abortion bans are not a remedy against eugenics: an empirical study

2023-1-1

Allocating organs through algorithms and equitable access to transplantation—a European human rights law approach

2023-1-1

The United Nations convention on the rights of persons with disabilities, neuroscience, and criminal legal capacity

2023-1-1